Treace Medical Concepts, Inc. Depreciation
Treace Medical Concepts, Inc. (TMCI) reported Depreciation of $1.50 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-07
- Treace Medical Concepts, Inc. depreciation for the quarter ending 2026-06-30 was $1.50M, a 34.78% decline year-over-year.
- Treace Medical Concepts, Inc. depreciation for the quarter ending 2025-06-30 was $2.30M.
| Period end | Depreciation 3 month | Depreciation 6 month |
|---|---|---|
| 2026-06-30 | $1.50M 10-Q · filed 2026-08-07 | $2.10M 10-Q · filed 2026-08-07 |
| 2025-06-30 | $2.30M 10-Q · filed 2026-08-07 | $4.40M 10-Q · filed 2026-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |